Together with tumor-intrinsic factors, including mismatch repair deficiency11 and mutational burden12, the presence of CD8+ tumor-infiltrating lymphocytes (TILs) is associated with better response to ICB and prolonged overall survival in extracranial tumors13,14 and BrM15. Here, CD8A is linked to neoplasm.